| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D321-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 |
| filingDate |
2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AR-091400-A2 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION THAT INCLUDES SULFAMIDE DERIVATIVES, PROCESS TO PREPARE IT AND USE OF SUCH COMPOUNDS TO PREPARE MEDICINES |
| abstract |
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the formula (1) wherein R¹ and R² are each independently selected from the group consisting of hydrogen and lower alkyl; R⁴ is selected from the group consisting of hydrogen and lower alkyl; a is an integer from 1 to 2; the R ring is selected from the group consisting of the compounds of formula (2) to (6); where b is an integer from 0 to 2 and where c is 0; each R⁵ is independently selected from the group consisting of halogen and lower alkyl; provided that, when the R ring is the compound of formula (6), then a is 1; or a pharmaceutically acceptable salt thereof. A process for preparing it and its uses in the preparation of medicines are also disclosed. |
| priorityDate |
2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |